8-K Announcements
6Material company update
May 15, 2026·SEC
Material company update
May 12, 2026·SEC
Material company update
Apr 30, 2026·SEC
NEXGEL, Inc.(NXGL)Earnings, Financials & Key Ratios
NXGL•NASDAQ
$0.52
Price updated Jun 27, 2026
AboutNEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.Show more
- Revenue$11M+31.5%
- EBITDA-$3M+15.0%
- Net Income-$3M+8.6%
- EPS (Diluted)-0.38+24.0%
- Gross Margin39.48%+24.8%
- EBITDA Margin-22.87%+35.4%
- Operating Margin-29.35%+28.3%
- Net Margin-26.27%+30.4%
- ROE-54.69%+6.3%
NXGL Price & Volume
NEXGEL, Inc. (NXGL) stock price & volume — 10-year historical chart
Loading chart...
Persistent Operational Losses Threaten Capital Structure Stability
Investment Thesis • Updated 2026Q1
VerdictNegative
Growth:Mixed
Profitability:Negative
Financial Position:Vulnerable
Cash Flow:Burning
Primary Risk:Imminent liquidity and dilution
"NEXGEL faces a challenging transition from contract manufacturing to a proprietary branded model, characterized by significant revenue contraction and persistent operating losses. While the firm's E-beam technology provides a theoretical competitive moat, the current trajectory of cash depletion and rising debt-to-equity ratios suggests an urgent need for external financing. Investors should monitor the company's ability to stabilize gross margins, which recently compressed to 40.0%, against the backdrop of a $21.9 million accumulated deficit."
Verdict Logic
the company's liquidity buffer has dwindled to just $208,000, creating an imminent risk of dilutive financing to cover ongoing quarterly operating losses.
NXGL Growth Metrics
NEXGEL, Inc. (NXGL) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years76.12%
3 Years77.33%
TTM10.14%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-2.39%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM14.29%
Return on Capital
10 Years-139.35%
5 Years-38.05%
3 Years-42.55%
Last Year-41.85%
Peers Comparison
Key metrics vs top competitors for NEXGEL, Inc. (NXGL)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $0.52 | $4.75M | -1.37 | 31.46% | -26.27% | -54.69% | — | |
| $0.86 | $8.56M | -0.97 | 13.03% | -55.45% | -79.65% | — | |
| $2.36 | $259.66K | -0.25 | — | -227.72% | -25.53% | — | |
| $0.97 | $12.43M | -1.08 | 11.8% | -25.66% | -476.72% | — | |
| $0.66 | $85.54M | -4.13 | -10.02% | -2.03% | -9.41% | — | |
| $6.62 | $182.19M | -14.09 | 10.2% | -14.82% | -35.57% | — |
Compare NXGL vs Peers
NEXGEL, Inc. (NXGL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
NXGL SEC Filings & Documents
NEXGEL, Inc. (NXGL) SEC filings — annual & quarterly reports (10-K, 10-Q)
Get notified when NXGL posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
NXGL Frequently Asked Questions
NEXGEL, Inc. (NXGL) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is NEXGEL, Inc.'s revenue?
NEXGEL, Inc. (NXGL) reported $11.3M in revenue for fiscal year 2025. This represents a 423% increase from $2.2M in 2016.
How fast is NEXGEL, Inc. growing?
NEXGEL, Inc. (NXGL) grew revenue by 31.5% over the past year. This is strong growth.
Is NXGL profitable?
NEXGEL, Inc. (NXGL) reported a net loss of $3.2M for fiscal year 2025.
Dividend & Returns
What is NXGL's return on equity?
NEXGEL, Inc. (NXGL) has a return on equity (ROE) of -54.7%. Negative ROE indicates the company is unprofitable.
What is NEXGEL, Inc.'s free cash flow?
NEXGEL, Inc. (NXGL) had negative free cash flow of $1.4M in fiscal year 2025, likely due to heavy capital investments.